Maxon, the largest pharmaceutical business giant in the United States, purchased celesio, the largest distributor in Europe, for us $8.3 billion
-
Last Update: 2013-10-29
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: e-drug manager.com.cn October 24, 2013, McKesson Corp., the largest drug distribution giant in the United States, announced that it would spend 8.3 billion US dollars (including debt) to acquire celesio, the largest drug distributor in Europe, a German competitor in the same industry It aims to forge a global market leader in the field of drug distribution, so as to enhance its ability to conduct procurement negotiations with global pharmaceutical manufacturers They have finalised a deal to acquire a 50.1 per cent stake in celesio, owned by Franz haniel & CIE, the largest shareholder in celesio, and will buy the remaining shares for 23 euros ($31.7) each, Mr McKesson said The market expects that the transaction volume of this M & A will reach 8.3 billion US dollars, which is also one of the largest M & A transactions in the pharmaceutical business field in recent years After the merger, macson will earn about 22 billion euros ($30.3 billion) of annual revenue from celesio, creating a global pharmaceutical wholesale and pharmacy group with annual revenue of more than 150 billion dollars Macson is headquartered in San Francisco In 1833, he started his business as a coach delivery company, and now he has developed into the largest pharmaceutical distribution group in the United States with hundreds of billions of dollars Together with his competitors, cardino and Meiyuan Bergen, macson has three parts of the entire pharmaceutical business in the United States The three companies have a market share of 95% in the United States Therefore, it has always been the research and learning object of Chinese medicine business Celesio is the largest European drug wholesaler based in Germany and rising in the fragmented European market B Genemannheimer, an analyst at Riley & Co, said celesio has some very strong brands across Europe, including Lloyds pharmacy, and that the deal would bring Maxon across Europe Although the purchase price of the deal seems to be very expensive, mcson is able to achieve very clear synergies and cost savings The deal will save $275 million to $325 million a year in the fourth year This will overshadow another alliance in the transatlantic drug trade, where Walgreen Co, a US peer, bought a 45% stake in alliance boots, a European chain drugstore chain with annual revenue of nearly $110 billion in 2012, but is still looking for further growth In March this year, Walgreen Co, a US peer, bought a 45% stake in alliance boots, a European chain drugstore chain with annual revenue of nearly $110 billion It also sought further growth with amerisourcebergen )An alliance was reached.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.